|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:GALM-STIP1 (FusionGDB2 ID:32090) |
Fusion Gene Summary for GALM-STIP1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GALM-STIP1 | Fusion gene ID: 32090 | Hgene | Tgene | Gene symbol | GALM | STIP1 | Gene ID | 130589 | 10963 |
| Gene name | galactose mutarotase | stress induced phosphoprotein 1 | |
| Synonyms | BLOCK25|GLAT|HEL-S-63p|IBD1 | HEL-S-94n|HOP|IEF-SSP-3521|P60|STI1|STI1L | |
| Cytomap | 2p22.1 | 11q13.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | aldose 1-epimerasealdose mutarotaseepididymis secretory sperm binding protein Li 63pgalactomutarotasegalactose enzyme activator | stress-induced-phosphoprotein 1Hsp70/Hsp90-organizing proteinNY-REN-11 antigenepididymis secretory sperm binding protein Li 94nhsc70/Hsp90-organizing proteinrenal carcinoma antigen NY-REN-11transformation-sensitive protein IEF SSP 3521 | |
| Modification date | 20200313 | 20200329 | |
| UniProtAcc | Q96C23 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000272252, ENST00000410063, | ENST00000358794, ENST00000305218, ENST00000538945, ENST00000543847, ENST00000540501, | |
| Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 10 X 11 X 7=770 |
| # samples | 5 | 12 | |
| ** MAII score | log2(5/32*10)=0.643856189774725 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(12/770*10)=-2.68182403997375 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GALM [Title/Abstract] AND STIP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | GALM(38903208)-STIP1(63967411), # samples:1 GALM(38903208)-STIP1(63967412), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | GALM | GO:0005975 | carbohydrate metabolic process | 12753898 |
| Hgene | GALM | GO:0006006 | glucose metabolic process | 12753898 |
| Hgene | GALM | GO:0006012 | galactose metabolic process | 12753898 |
| Fusion gene breakpoints across GALM (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across STIP1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | UCEC | TCGA-EY-A212 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| ChimerDB4 | UCEC | TCGA-EY-A212-01A | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
Top |
Fusion Gene ORF analysis for GALM-STIP1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000272252 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| In-frame | ENST00000272252 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| In-frame | ENST00000272252 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| 5CDS-intron | ENST00000272252 | ENST00000543847 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| 5CDS-intron | ENST00000272252 | ENST00000540501 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| intron-3CDS | ENST00000410063 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| intron-3CDS | ENST00000410063 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| intron-3CDS | ENST00000410063 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| intron-intron | ENST00000410063 | ENST00000543847 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| intron-intron | ENST00000410063 | ENST00000540501 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + |
| In-frame | ENST00000272252 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| In-frame | ENST00000272252 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| In-frame | ENST00000272252 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| 5CDS-intron | ENST00000272252 | ENST00000543847 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| 5CDS-intron | ENST00000272252 | ENST00000540501 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| intron-3CDS | ENST00000410063 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| intron-3CDS | ENST00000410063 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| intron-3CDS | ENST00000410063 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| intron-intron | ENST00000410063 | ENST00000543847 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| intron-intron | ENST00000410063 | ENST00000540501 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000358794 | STIP1 | chr11 | 63967411 | + | 1623 | 597 | 252 | 1205 | 317 |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000305218 | STIP1 | chr11 | 63967411 | + | 1623 | 597 | 252 | 1205 | 317 |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000538945 | STIP1 | chr11 | 63967411 | + | 1488 | 597 | 252 | 1205 | 317 |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000358794 | STIP1 | chr11 | 63967412 | + | 1623 | 597 | 252 | 1205 | 317 |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000305218 | STIP1 | chr11 | 63967412 | + | 1623 | 597 | 252 | 1205 | 317 |
| ENST00000272252 | GALM | chr2 | 38903208 | + | ENST00000538945 | STIP1 | chr11 | 63967412 | + | 1488 | 597 | 252 | 1205 | 317 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000272252 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 0.003073274 | 0.9969267 |
| ENST00000272252 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 0.003073274 | 0.9969267 |
| ENST00000272252 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 0.004434919 | 0.995565 |
| ENST00000272252 | ENST00000358794 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + | 0.003073274 | 0.9969267 |
| ENST00000272252 | ENST00000305218 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + | 0.003073274 | 0.9969267 |
| ENST00000272252 | ENST00000538945 | GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967412 | + | 0.004434919 | 0.995565 |
Top |
Fusion Genomic Features for GALM-STIP1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 1.07E-11 | 1 |
| GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 1.07E-11 | 1 |
| GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 1.07E-11 | 1 |
| GALM | chr2 | 38903208 | + | STIP1 | chr11 | 63967411 | + | 1.07E-11 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for GALM-STIP1 |
| Go to FGviewer for the breakpoints of chr2:38903208-chr11:63967411 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GALM | . |
| FUNCTION: Mutarotase that catalyzes the interconversion of beta-D-galactose and alpha-D-galactose during galactose metabolism (PubMed:12753898). Beta-D-galactose is metabolized in the liver into glucose 1-phosphate, the primary metabolic fuel, by the action of four enzymes that constitute the Leloir pathway: GALM, GALK1 (galactokinase), GALT (galactose-1-phosphate uridylyltransferase) and GALE (UDP-galactose-4'-epimerase) (PubMed:30451973). Involved in the maintenance of the equilibrium between the beta- and alpha-anomers of galactose, therefore ensuring a sufficient supply of the alpha-anomer for GALK1 (PubMed:12753898). Also active on D-glucose although shows a preference for galactose over glucose (PubMed:12753898). {ECO:0000269|PubMed:12753898, ECO:0000269|PubMed:30451973}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GALM | chr2:38903208 | chr11:63967411 | ENST00000272252 | + | 2 | 7 | 81_82 | 115.0 | 343.0 | Region | Beta-D-galactose binding |
| Hgene | GALM | chr2:38903208 | chr11:63967412 | ENST00000272252 | + | 2 | 7 | 81_82 | 115.0 | 343.0 | Region | Beta-D-galactose binding |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 492_531 | 341.0 | 544.0 | Domain | Note=STI1 2 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 492_531 | 341.0 | 544.0 | Domain | Note=STI1 2 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 360_393 | 341.0 | 544.0 | Repeat | Note=TPR 7 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 394_427 | 341.0 | 544.0 | Repeat | Note=TPR 8 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 428_461 | 341.0 | 544.0 | Repeat | Note=TPR 9 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 360_393 | 341.0 | 544.0 | Repeat | Note=TPR 7 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 394_427 | 341.0 | 544.0 | Repeat | Note=TPR 8 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 428_461 | 341.0 | 544.0 | Repeat | Note=TPR 9 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GALM | chr2:38903208 | chr11:63967411 | ENST00000272252 | + | 2 | 7 | 176_178 | 115.0 | 343.0 | Region | Beta-D-galactose binding |
| Hgene | GALM | chr2:38903208 | chr11:63967412 | ENST00000272252 | + | 2 | 7 | 176_178 | 115.0 | 343.0 | Region | Beta-D-galactose binding |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 130_169 | 341.0 | 544.0 | Domain | Note=STI1 1 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 130_169 | 341.0 | 544.0 | Domain | Note=STI1 1 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 222_239 | 341.0 | 544.0 | Motif | Bipartite nuclear localization signal | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 222_239 | 341.0 | 544.0 | Motif | Bipartite nuclear localization signal | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 225_258 | 341.0 | 544.0 | Repeat | Note=TPR 4 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 259_292 | 341.0 | 544.0 | Repeat | Note=TPR 5 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 300_333 | 341.0 | 544.0 | Repeat | Note=TPR 6 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 38_71 | 341.0 | 544.0 | Repeat | Note=TPR 2 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 4_37 | 341.0 | 544.0 | Repeat | Note=TPR 1 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967411 | ENST00000305218 | 7 | 14 | 72_105 | 341.0 | 544.0 | Repeat | Note=TPR 3 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 225_258 | 341.0 | 544.0 | Repeat | Note=TPR 4 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 259_292 | 341.0 | 544.0 | Repeat | Note=TPR 5 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 300_333 | 341.0 | 544.0 | Repeat | Note=TPR 6 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 38_71 | 341.0 | 544.0 | Repeat | Note=TPR 2 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 4_37 | 341.0 | 544.0 | Repeat | Note=TPR 1 | |
| Tgene | STIP1 | chr2:38903208 | chr11:63967412 | ENST00000305218 | 7 | 14 | 72_105 | 341.0 | 544.0 | Repeat | Note=TPR 3 |
Top |
Fusion Gene Sequence for GALM-STIP1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000272252_ENST00000358794_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(transcript)=1623nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC TCTTTCCCCTGCCCCTAGTTGCTGTCTCGGCTGCTCTCCCATAGTTGGTTTTTTTTTTATTTGGGGCAGTGGGCATGTTATGGGGAGGGG AGGGGGTTCTTCCAGCCTCAGGTCCCAGCTGTCTCACGTTGTTTATTCTGCGTCCCCTTCTCCAATAAAACAAGCCAGTTGGGCGTGGTT >In-frame_ENST00000272252_ENST00000358794_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- >In-frame_ENST00000272252_ENST00000305218_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(transcript)=1623nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC TCTTTCCCCTGCCCCTAGTTGCTGTCTCGGCTGCTCTCCCATAGTTGGTTTTTTTTTTATTTGGGGCAGTGGGCATGTTATGGGGAGGGG AGGGGGTTCTTCCAGCCTCAGGTCCCAGCTGTCTCACGTTGTTTATTCTGCGTCCCCTTCTCCAATAAAACAAGCCAGTTGGGCGTGGTT >In-frame_ENST00000272252_ENST00000305218_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- >In-frame_ENST00000272252_ENST00000538945_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(transcript)=1488nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC >In-frame_ENST00000272252_ENST00000538945_TCGA-EY-A212_GALM_chr2_38903208_+_STIP1_chr11_63967411_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- >In-frame_ENST00000272252_ENST00000358794_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(transcript)=1623nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC TCTTTCCCCTGCCCCTAGTTGCTGTCTCGGCTGCTCTCCCATAGTTGGTTTTTTTTTTATTTGGGGCAGTGGGCATGTTATGGGGAGGGG AGGGGGTTCTTCCAGCCTCAGGTCCCAGCTGTCTCACGTTGTTTATTCTGCGTCCCCTTCTCCAATAAAACAAGCCAGTTGGGCGTGGTT >In-frame_ENST00000272252_ENST00000358794_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- >In-frame_ENST00000272252_ENST00000305218_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(transcript)=1623nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC TCTTTCCCCTGCCCCTAGTTGCTGTCTCGGCTGCTCTCCCATAGTTGGTTTTTTTTTTATTTGGGGCAGTGGGCATGTTATGGGGAGGGG AGGGGGTTCTTCCAGCCTCAGGTCCCAGCTGTCTCACGTTGTTTATTCTGCGTCCCCTTCTCCAATAAAACAAGCCAGTTGGGCGTGGTT >In-frame_ENST00000272252_ENST00000305218_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- >In-frame_ENST00000272252_ENST00000538945_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(transcript)=1488nt_BP=597nt GACGAGCCAAGGAAAAAAAGTACAAGTGTGGCTGCAAAGTTTGCCCCTCTTGTTACCCTCAGGCAAATGATTGATTTAGAAAGGCCCCAG GGGCTATTTTTTGCAGGAACGGTCACTCCCTAAATCCAGGCAGGGAAAGGGAGGAGTCTGAGCCGAGTCACGCCCCTTCTCCTGTAAACT TGGGTCGCCTCTAGCTTAGCGAGCGCTGGAGTTTGAAGAGCGGGCAGTGGCTGCACACGCCAAACTTTCCCTATGGCTTCGGTGACCAGG GCCGTGTTTGGAGAGCTGCCCTCGGGAGGAGGGACAGTGGAGAAGTTCCAGCTGCAGTCAGACCTCTTGAGAGTGGACATCATCTCCTGG GGCTGCACGATCACAGCCCTAGAGGTCAAAGACAGGCAGGGGAGAGCCTCGGACGTGGTGCTTGGCTTCGCCGAGTTGGAAGGATACCTC CAAAAGCAGCCATACTTTGGAGCAGTTATTGGGAGGGTGGCCAACCGAATCGCCAAAGGAACCTTCAAGGTGGATGGGAAGGAGTATCAC CTGGCCATTAACAAGGAACCCAACAGTCTGCATGGAGGAGTCAGAGGGTTTGATAAAGCAGAGAAAATCCTGAAGGAGCAAGAGCGGCTG GCCTACATAAACCCCGACCTGGCTTTGGAGGAGAAGAACAAAGGCAACGAGTGTTTTCAGAAAGGGGACTATCCCCAGGCCATGAAGCAT TATACAGAAGCCATCAAAAGGAACCCGAAAGATGCCAAATTATACAGCAATCGAGCTGCCTGCTACACCAAACTCCTGGAGTTCCAGCTG GCACTCAAGGACTGTGAGGAATGTATCCAGCTGGAGCCGACCTTCATCAAGGGTTATACACGGAAAGCCGCTGCGCTGGAAGCGATGAAG GACTACACCAAAGCCATGGATGTGTACCAGAAGGCGCTAGACCTGGACTCCAGCTGTAAGGAGGCGGCAGACGGCTACCAGCGCTGTATG ATGGCGCAGTACAACCGGCACGACAGCCCCGAAGATGTGAAGCGACGAGCCATGGCCGACCCTGAGGTGCAGCAGATCATGAGTGACCCA GCCATGCGCCTTATCCTGGAACAGATGCAGAAGGACCCCCAGGCACTCAGCGAACACTTAAAGAATCCTGTAATAGCACAGAAGATCCAG AAGCTGATGGATGTGGGTCTGATTGCAATTCGGTGATGACTTGTTCATCCCCCCTTCCCTTCGCCCTCATGTGGAAAGAGGAGCTGGGAC CGCGGCGAGCAGCACGGAGCGGAAGGGAGAGCAGGGGAGAGAAGGCCTCATCTCTCTATATTTATACATAACCCCGGGGAAGACACAGAG ACTCGTACCTGCGCTGTTTGTGCCGCCGCTGCCTCTGGGCCCTCCCAGCACACGCATGGTCTCTTCACCGCTGCCCTCGAGTTCCATGTC >In-frame_ENST00000272252_ENST00000538945_TCGA-EY-A212-01A_GALM_chr2_38903208_+_STIP1_chr11_63967412_length(amino acids)=317AA_start in transcript=252_stop in transcript=1205 MASVTRAVFGELPSGGGTVEKFQLQSDLLRVDIISWGCTITALEVKDRQGRASDVVLGFAELEGYLQKQPYFGAVIGRVANRIAKGTFKV DGKEYHLAINKEPNSLHGGVRGFDKAEKILKEQERLAYINPDLALEEKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTK LLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYNRHDSPEDVKRRAMADPEVQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for GALM-STIP1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GALM-STIP1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for GALM-STIP1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | STIP1 | C0011581 | Depressive disorder | 1 | PSYGENET |
| Tgene | STIP1 | C0025202 | melanoma | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies